Birati Edo Y, Rame J Eduardo
Division of Cardiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Division of Cardiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Crit Care Clin. 2014 Jul;30(3):629-37. doi: 10.1016/j.ccc.2014.03.005.
Managing patients after heart transplantation is challenging, since these patients have unique clinical complications (associated with the immunosuppressive therapy and cardiac allograft rejection) together with atypical clinical presentations for infection and systemic inflammatory response syndrome. Survival rates have improved substantially with the use of new immunosuppressive drugs. High vigilance, early diagnosis, and appropriate intervention for allograft-related and non-allograft-related syndromes with significant morbidity and mortality are the keys to long-term survival of patients after transplantation.
心脏移植术后患者的管理具有挑战性,因为这些患者有独特的临床并发症(与免疫抑制治疗和心脏移植排斥反应相关),同时伴有感染和全身炎症反应综合征的非典型临床表现。随着新型免疫抑制药物的使用,生存率有了显著提高。对具有显著发病率和死亡率的移植相关和非移植相关综合征保持高度警惕、早期诊断并进行适当干预,是移植后患者长期生存的关键。